Today Kedrion Biopharma announced the nationwide commercial availability of QIVIGY, its FDA‑approved 10% Intravenous ...
1d
"I was fighting to survive": Patients still struggle with preauthorization despite promise of reform
Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, but patient advocates and medical providers remain skeptical.
ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA” or the "Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...
In 1996, a previously healthy 5-year-old girl presented to a local urgent care clinic with a 3-day history of fever and a progressive, generalized vesicular rash, diagnosed as varicella with a known ...
Johnson & Johnson , a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug ...
Medical evidence -- Independent datasets and a peer-reviewed study presented at ACAAI 2025 and published in the Journal of Clinical Immunology showed 71% clinical improvement, and significant ...
Q4 2025 Earnings Call February 25, 2026 4:30 PM ESTCompany ParticipantsAdam Grossman - Co-Founder, President, CEO ...
Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients ...
Checkpoint inhibitors may work best when they are given early in the day, suggests clinical data from a phase III trial in patients with non-small-cell lung cancer (NSCLC). Patients who received a PD1 ...
The idea that cancer treatment might work better at certain times of day has circulated for decades but has rarely faced rigorous clinical testing. Now, a randomized trial of 210 people with advanced ...
The findings of the pivotal RESET-RA trial demonstrate the clinical benefits and safety of an implanted neuromodulation device that stimulates the vagus nerve for the treatment of rheumatoid arthritis ...
Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results